Significance of glycosylated haemoglobin determination for the assessment of lower-extremity amputation risk in patients with diabetic foot

Q4 Pharmacology, Toxicology and Pharmaceutics

Arhiv za Farmaciju Pub Date : 2019-01-01 DOI:10.5937/arhfarm1902051x

T. Stefanović, S. Bosić, J. Vekić, V. Spasojević-Kalimanovska, V. Todorovic, Marina Pijanović, A. Zeljković, A. Stefanović, Z. Jelić-Ivanović

引用次数: 0

查看原文本刊更多论文

糖化血红蛋白测定对糖尿病足患者下肢截肢风险评估的意义

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Arhiv za Farmaciju Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science

自引率

0.00%

发文量

审稿时长

12 weeks